Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for CorMedix (CRMD) over the last 11 years, with Q3 2025 value amounting to $278684.0.

  • CorMedix's Other Accumulated Expenses rose 4515.17% to $278684.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $278684.0, marking a year-over-year increase of 4515.17%. This contributed to the annual value of $122357.0 for FY2024, which is N/A changed from last year.
  • As of Q3 2025, CorMedix's Other Accumulated Expenses stood at $278684.0, which was up 4515.17% from $136298.0 recorded in Q2 2025.
  • Over the past 5 years, CorMedix's Other Accumulated Expenses peaked at $436290.0 during Q2 2024, and registered a low of $54763.0 during Q3 2023.
  • Over the past 5 years, CorMedix's median Other Accumulated Expenses value was $102998.0 (recorded in 2021), while the average stood at $134361.1.
  • Per our database at Business Quant, CorMedix's Other Accumulated Expenses skyrocketed by 30924.8% in 2024 and then tumbled by 6875.98% in 2025.
  • CorMedix's Other Accumulated Expenses (Quarter) stood at $94736.0 in 2021, then crashed by 31.96% to $64456.0 in 2022, then decreased by 15.04% to $54763.0 in 2023, then surged by 123.43% to $122357.0 in 2024, then surged by 127.76% to $278684.0 in 2025.
  • Its Other Accumulated Expenses was $278684.0 in Q3 2025, compared to $136298.0 in Q2 2025 and $87423.0 in Q1 2025.